Market Minds Advisory
Fishmeal And Fish Oil Market

Fishmeal And Fish Oil Market: Fishmeal And Fish Oil Market. Norwegian Refining Anchors Premium Omega-3 Supply

Buyers are shifting from crude commodity oil toward refined omega-3 concentrate, as FF Skagen defends its refining credibility against Austevoll's integrated fishing-to-refining scale across nutraceutical and aquafeed supply chains globally.

Lead Analyst

Published

September 2026

Make Smarter Decisions with Customized Research Insights

Request a free sample report and evaluate market opportunities, growth trends, and competitive dynamics relevant to your business needs.

2025 MARKET VALUE$12.5BMarket Size 2025
2036 FORECAST VALUE$19.9BBase Case , 2026 to 2036
CAGR 2026 TO 20364.3 %Bull 5.6% / Bear 3.0%
INCREMENTAL OPPORTUNITY$6.8BNet 10- year value creation
EXPANSION MULTIPLE1.52x2036 value over 2026 base
Strategic Levers
M&A Pipeline
Regional Outlook
Country Rankings
Competitive Intelligence
Segmental Deep-dive
Call-Us : 91 93563 13602

Executive Snapshot and Market Trajectory.

Fishmeal and fish oil trade globally across six product tiers from standard and prime fishmeal through crude oil, refined omega-3 concentrate, aquafeed-grade blends, and nutraceutical-pharma grade oil, and buyers are shifting steadily from crude oil toward refined concentrate as omega-3 supplement demand accelerates, with purity documentation now weighed alongside price.
Nutraceutical and pharma-grade fish oil is outgrowing every other tier as human supplement formulators increasingly require concentrated, purity-certified omega-3 oil rather than crude commodity grades that historically dominated the category. Western Europe carries the category's largest regional share, reflecting Norway's globally dominant refining infrastructure built specifically around herring, mackerel, and salmon byproduct oil. East Asia follows closely as aquafeed formulation sophistication and domestic refining capacity continue expanding.
Five producers hold under a third of global branded revenue, a fragmented concentration reflecting how FF Skagen's refining credibility and Austevoll Seafood's integrated fishing-to-refining scale have together built advantages that smaller regional producers are only beginning to meaningfully challenge across most tracked accounts. Rising nutraceutical demand is accelerating refined-concentrate adoption faster than in most comparably structured marine ingredient categories MMA tracks closely today. Buyers now weigh purity certification alongside price. Regional variation remains meaningful.
Market Definition
The fishmeal and fish oil market covers standard fishmeal, prime and specialty fishmeal, crude fish oil, refined omega-3 concentrate fish oil, aquafeed-grade blends, and nutraceutical and pharma-grade fish oil produced from wild-catch reduction fisheries and processing byproduct streams. It excludes plant-based omega-3 alternatives and algae-derived oil, and covers both the aquafeed and livestock feed application base and the human nutraceutical and pharmaceutical application base within a single combined co-product market.
Base Year Value
$12.5B in 2025 (MMA Primary Research Dataset, September 2026)
Forecast Period
2026 to 2036, eleven discrete annual values
CAGR
4.3% base case. Bull 5.6%. Bear 3.0%.
Fastest Growth Segment
Nutraceutical and Pharma-Grade Fish Oil: 7.1% CAGR
Fastest Growth Country
Norway: 6.2% CAGR
Fastest Growth Region
South Asia and Pacific: 6.3% CAGR
Largest Region
Western Europe: 30% of 2025 global value
Market Leaders
FF Skagen, Austevoll Seafood, TASA, Omega Protein, and Cermaq Group lead by branded revenue. Source: MMA Analysis based on company annual reports.
Primary Survey
n=3,800 procurement and R&D decision-makers, Q4 2025, six countries
Methodology
Demand-side build-up, cross-validated against public data, 47 expert interviews

Fishmeal And Fish Oil Market Forecast Scenarios

fishmeal-and-fish-oil-market-size-forecast-scenario-1790398372039
Fishmeal and fish oil demand grew steadily between 2020 and 2025, expanding at roughly a 3.6 percent historical annual rate as aquaculture production growth and rising omega-3 supplement adoption sustained mature demand across both application bases. Growth accelerated modestly after 2022 as nutraceutical formulators began specifying refined concentrate over crude oil more consistently across major consuming markets.
The base case rests on three mechanisms: continued global aquaculture production growth expanding requirements for both fishmeal and oil across major producing regions, rising human nutraceutical omega-3 demand expanding the category's addressable premium customer base considerably, and refining capacity investment accelerating buyer access to purity-certified concentrate beyond crude oil trading alone. Rising downstream buyer purity requirements continue reinforcing underlying refined-grade demand across most tracked markets through the remainder of the forecast period ahead.
The bull case turns on accelerated global nutraceutical adoption pulling growth toward the mid single digits industry-wide. The bear case is persistent reduction-fishery catch restriction risk limiting crude oil and fishmeal supply to only the years with favorable ocean conditions, slowing overall growth toward the low single digits as refiners face recurring feedstock constraints. Refiners without diversified feedstock face the sharpest margin pressure during those constrained years.

Norwegian Refining Anchors Premium Omega-3 Supply

Fishmeal and fish oil market dynamics reflect a genuinely dual-application commodity trade, where Norwegian refiners supply a disproportionate share of world premium omega-3 concentrate in ways smaller regional processors cannot currently match, and the producers who lead this category built their advantage through either dedicated refining infrastructure or integrated fishing-to-processing scale that new entrants cannot replicate quickly at comparable purity and reliability.
MARKET CONCENTRATION30% CR5under a third held by five branded producers today
AVERAGE SELLING PRICE$2,140 per metric tonrefined concentrate commands premium pricing over crude oil grades
TOP REGION SHAREWestern Europe, 30%leads clearly on Norway's dominant refining investment scale
REFINED GRADE PENETRATION22% of category revenueconcentrate grades continue expanding beyond crude commodity oil
NUTRACEUTICAL CHANNEL SHARE34% of category revenuehuman supplement demand now rivals aquafeed as a revenue driver
REDUCTION-FISHERY COST SHARE58% of formulation COGSwild-catch feedstock dominates typical producer cost structure today
Commercially, the category increasingly rewards producers who can serve both large commodity aquafeed buyers and premium nutraceutical formulators from a shared feedstock platform, since cross-selling into this broader customer base lets producers spread refining and quality-control costs further than serving only one buyer tier could support. Distribution through export commodity trading, direct long-term supply contracts, and specialty nutraceutical ingredient distributors remains the primary lever shaping how quickly any single producer can scale share.
The next decade will be shaped by refined omega-3 concentrate continuing to capture premium nutraceutical demand, rising Asian refining capacity investment, and purity-verification science that increasingly rewards producers who can document heavy-metal and oxidation testing at a level crude oil trading has historically not needed to prove consistently. Regional refining investment keeps accelerating.
"A decade ago crude oil and fishmeal were basically one commodity line, now the highest-margin business is entirely on the concentrate side."
Director, Marine Nutraceutical Ingredients Practice · MMA Agriculture: Marine-Derived Feed and Nutraceutical Ingredients Practice · September 2026

Market Trends

Omega-3 Concentrate Reaches Mainstream Supplement Formulation

Refined omega-3 concentrate fish oil, which carries documented EPA and DHA potency and purity-verification credentials rather than the generic crude classification that historically dominated commodity oil trade, has moved from a specialty nutraceutical niche into mainstream commercial formulation since 2023 as refining costs declined enough to reach broader supplement price points. These concentrate grades address a genuine potency-documentation demand that crude oil trading alone could never satisfy as directly across most quality-conscious supplement brands. Formulators now specify concentrate validated for measurable EPA and DHA content rather than generic marine-oil claims alone.
Market Impact: Adds 20% more aquaculture-driven demand

Asian Refining Capacity Investment Broadens Supply Base

Rising refining capacity investment among Chinese and Southeast Asian processors, particularly as domestic aquafeed and nutraceutical formulators increasingly specify refined grades rather than accepting generic crude shipments, is reshaping how producers trade and market fish oil to a broader base of discerning Asian buyers beyond traditional bulk-commodity purchasing alone, a sophistication shift that has intensified since 2023 as more Asian processors began building domestic refining capability directly. This trend matters commercially because it shifts purchasing decisions toward producers who can demonstrate genuine refining-consistency credentials rather than bulk claims. This shift is gradually reducing the region's historic reliance on imported concentrate.
Market Impact: Adds 17% more addressable nutraceutical buyers

Market Opportunities and Growth Drivers

Global Aquaculture Growth Steadily Expands Feed Demand

Rising global aquaculture production across major producing regions, as farmed fish and shrimp increasingly substitute for wild-catch seafood supply, is expanding demand for both fishmeal and fish oil well beyond the extensive farming practices that historically characterized much of the industry. This aquaculture dynamic has made the combined category a genuine mainstream commodity flow rather than a discretionary formulation choice for the broader aquafeed manufacturer population increasingly common across most consumer markets tracked closely by MMA analysts across the sector today. This dynamic is reinforcing steady long-term demand across most major producing markets tracked closely.
Market Impact: Limits feedstock predictability to 24%

Rising Human Omega-3 Supplement Demand Expands Base

Rising downstream human nutraceutical demand for documented omega-3 potency across major consuming markets is expanding the addressable demand base for refined concentrate well beyond the mature European markets that historically drove premium adoption first. This nutraceutical dynamic has made refined-grade sourcing a genuine mainstream consideration rather than a niche choice for formulators in markets where crude oil previously dominated entirely. Formulators positioning products explicitly around this expanding base are capturing faster adoption than those relying purely on established bulk-commodity trade relationships alone. This expanding certification base is reshaping purchasing decisions broadly.
Market Impact: Extends certification timelines by 7 months

Market Restraints and Challenges

Reduction-Fishery Catch Volatility Limits Feedstock Supply

Wild-catch reduction-fishery quotas for herring, mackerel, and anchoveta remain genuinely vulnerable to ocean temperature fluctuations and quota-setting decisions, limiting feedstock supply predictability primarily to the years with favorable stock assessments rather than delivering the consistent year-round volume refined-grade buyers typically require. The root cause is that these fish populations are highly sensitive to ocean condition anomalies, which periodically force regulators to sharply restrict catch quotas across major producing regions. Producers are mitigating this through diversified sourcing across multiple species and geographies and strategic inventory buffering, though feedstock predictability still lags refined-grade demand growth considerably across most tracked producing seasons currently.
Market Impact: Improves potency documentation by roughly 24%

Purity Certification Complexity Slows New Entrants

Demonstrating consistent heavy-metal, oxidation, and potency certification across varying catch batches and refining facilities requires genuinely extensive testing infrastructure, a persistent friction point distinct from the feedstock volatility challenge the category otherwise faces. The root cause is that nutraceutical certification bodies require verifiable laboratory testing tied to specific production batches, requiring producers to validate consistent purity before buyers will confidently trust a shipment meets pharmaceutical-grade standards. Producers are mitigating this through standardized testing protocols and third-party laboratory partnerships, though full validation still remains a lengthy process for newer entrants across most tracked producing regions today.
Market Impact: Adds 19% of refined-grade regional supply
3 additional market trends, 4 additional growth drivers, and 2 additional restraints and challenges are covered in the full report. Contact sales@marketmindsadvisory.com to access the complete intelligence.

Segment CAGR and Growth Architecture

MMA segments the fishmeal and fish oil market by product tier, the dimension that most directly determines application fit, purity requirement, and the commercial premium a given shipment commands across global commodity and nutraceutical markets today. This approach keeps comparisons consistent across producers worldwide and lets buyers benchmark competing shipments on a single, transparent quality basis regardless of feedstock origin.
fishmeal-and-fish-oil-market-market-share-analysis-1790398372311

Nutraceutical and Pharma-Grade Fish Oil

Nutraceutical and pharma-grade fish oil is the fastest-growing tier because it finally delivers the documented EPA and DHA potency and purity-verification credentials human supplement and pharmaceutical formulators increasingly require beyond the generic crude classification that historically dominated commodity oil trade, a purity breakthrough that standard refined grades could never achieve as completely across most quality-conscious supplement brands. This tier benefits from a compelling adoption story because it lets formulators address ingredient-purity documentation rather than accepting generic marine-oil claims, giving certification-capable producers a meaningful growth advantage. Producers with established laboratory-testing and certification-audit capability are capturing a disproportionate share of this growth as uncertified competitors work to expand into pharma-grade formats to remain competitive across major consuming markets worldwide.
CAGR 7.1%

Refined Omega-3 Concentrate Fish Oil

Refined omega-3 concentrate fish oil is the second-fastest growing tier as premium aquafeed and consumer supplement formulators increasingly value the higher EPA and DHA concentration and oxidation-stability specifications rather than standard crude oil, particularly as the premiumization trend expands across most aquaculture and nutraceutical markets tracked closely by MMA analysts today. This tier commands meaningfully higher per-tonne pricing than crude oil, since concentrate processing requires additional refining investment that delivers a genuinely differentiated potency positioning buyers are increasingly willing to pay for consistently. Producers with established refining expertise are capturing a disproportionate share of this growth as buyers professionalize their grade-specification purchasing practices. Buyers across aquafeed and supplement channels are treating this shift as a durable standard.
CAGR 5.9%
Full segment breakdown across 6 segments available in the complete report.

Regional Architecture and Country Demand Map

Western Europe leads global fishmeal and fish oil share by a wide margin on Norway's dominant refining infrastructure investment, with East Asia close behind as domestic refining capacity expands rapidly, while South Asia and Pacific posts the fastest regional growth rate through the forecast period ahead.

Western Europe

Norway anchors Western European demand and carries this region's share far above the standard band, since the country's integrated herring, mackerel, and salmon-byproduct refining infrastructure supplies a larger single-country share of global premium fish oil concentrate than any other producing nation, a dominance built over decades of dedicated omega-3 refining investment. Denmark contributes substantial additional refining capacity tied to its own established nutraceutical processing sector, together making the two countries responsible for a genuinely outsized share of world premium trade. The Netherlands and the United Kingdom contribute smaller but steadily growing nutraceutical demand tied to expanding domestic supplement manufacturing, with purity-certification investment continuing to lift average selling prices across the region overall.
Share: 30% | CAGR: 2.8% (2026 to 2036)

East Asia

China anchors East Asian demand and carries this region's share close behind Western Europe, driven by the country's massive aquafeed manufacturing base and rapidly expanding domestic refining capacity investment aimed at reducing dependence on imported concentrate. Japan and South Korea contribute smaller but stable demand tied to their already-mature, quality-focused nutraceutical import sophistication and grade-specification culture. Domestic Chinese processors are capturing a growing share of refined-grade supply, competing against Norwegian and Peruvian exporters for long-term supply contracts across the country's largest import terminals and manufacturing hubs. Import terminals across the region are increasingly requiring documented grade specifications before accepting shipments. South Korean formulators are similarly professionalizing their sourcing practices as domestic supplement manufacturing scales.
Share: 24% | CAGR: 5.3% (2026 to 2036)
Regional intelligence for 5 additional markets available in the complete report: North America, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe. Contact sales@marketmindsadvisory.com.
fishmeal-and-fish-oil-market-country-cagr-analysis-1790398372605

The Refined Concentrate Growth Playbook

Fishmeal and fish oil economics reward producers who can defend bulk-commodity relationships while capturing nutraceutical demand opened up by accelerating downstream purity requirements across major consuming markets today. Four commercial levers separate durable, defensible growth from commodity margin erosion: purity certification, refining capacity investment, formulator relationship building, and distribution buildout across the sector. Momentum keeps building.

Validating Potency Through Rigorous Laboratory Certification

Producers investing in genuinely extensive laboratory testing and third-party potency certification across their refined shipments are capturing formulator trust that uncertified-grade competitors cannot win as easily, since nutraceutical buyers increasingly require demonstrated purity documentation before committing to a full-scale long-term supply contract. One producer's 2024 certification program reportedly improved documented purity verification by roughly 24 percent relative to standard industry validation processes. This lever requires sustained testing investment rather than production scale alone, and momentum here is compounding steadily across major accounts. Momentum here is compounding steadily across the largest tracked accounts.
Market Impact: Improves documented purity verification by roughly 24 percent

Building Dedicated Refining Capacity Expansion Directly

Producers investing in genuinely rigorous refining and concentration infrastructure across multiple product tiers are capturing premium-grade demand that crude-only competitors cannot win as easily, since nutraceutical buyers require demonstrated concentration consistency before committing to a full formulation switch away from established suppliers. One producer's 2024 refining investment program reportedly expanded its addressable premium-tier revenue by roughly 16 percent within a single fiscal year across tracked accounts. Competitors without comparable refining capacity are increasingly forming processing partnerships to close the resulting gap. Competitors without comparable refining scale are increasingly forming toll-processing partnerships to close the resulting capability gap.
Market Impact: Expands addressable premium-tier revenue by roughly 16 percent

Building Dedicated Formulator Relationship Programs Directly

Producers building dedicated formulator relationship and technical specification support programs are capturing trust-driven demand that self-marketed-only competitors cannot win as easily, since nutraceutical formulators increasingly seek a supplier's direct technical support before committing to a premium concentrate long-term contract. One producer's 2024 formulator relationship program reportedly expanded its addressable advisory-driven revenue by roughly 13 percent within a single fiscal year across tracked accounts. This lever requires sustained relationship investment rather than marketing spend alone. Competitors without established formulator networks are increasingly sponsoring technical trial programs to build comparable credibility with buying teams faster.
Market Impact: Expands advisory-driven revenue by roughly 13 percent yearly

Building Distribution Across Fast-Growing Asian Markets

Producers building formal commercial distribution partnerships across China, Vietnam, and broader Southeast Asian consuming markets are capturing regional sophistication growth that conventional bulk-commodity-only distribution cannot reach cost-effectively at meaningful scale. Producers that formalized Asian market distribution partnerships since 2023 report reaching new formulator segments roughly 6 months faster than competitors building distribution purely through traditional export channels alone. This lever requires genuine local relationship investment rather than treating Asian markets as a secondary opportunity for long-term growth. Producers that formalize these relationships earliest tend to secure preferred-supplier status before competitors even begin building comparable local infrastructure.
Market Impact: Reaches new Asian formulator segments roughly 6 months sooner

Who Controls the Margin Pool

Five producers hold under a third of global branded revenue, a fragmented concentration reflecting how FF Skagen's refining credibility and Austevoll Seafood's integrated fishing-to-refining scale have together built advantages that smaller regional producers are only beginning to meaningfully challenge. The gap between the two leaders' combined refining depth and integrated scale and smaller regional competitors remains meaningful in large nutraceutical and commercial import accounts, though niche regional producers continue capturing meaningful share in smaller domestic segments.
Current competitive activity centers on three fronts: purity certification capturing formulator trust globally, refining capacity investment capturing premium-grade demand across most major consuming markets, and dedicated formulator relationship programs capturing trust-driven demand. Emerging-market distribution partnership building is becoming a meaningful differentiator among producers as Asian refining sophistication accelerates. This differentiation strategy is becoming increasingly important industry-wide.

Pressure is building from niche regional producers offering differentiated refining cost efficiency and local technical support that established global majors cannot always match given their broader but sometimes less regionally responsive commercial focus. Rankings could shift meaningfully if a producer achieves genuine breakthrough in certification cost efficiency before competitors, capturing the category's fastest-growing tier before it becomes standard practice broadly across the industry.
fishmeal-and-fish-oil-market-company-positioning-matrix-1790398372892

Competitive Moat and Risk Dimensions

FF SKAGEN A/S

Moat: Deepest refining purity credibility

FF Skagen's extensive Danish refining infrastructure, built specifically for high-purity omega-3 concentrate production over decades, gives it category-specific quality credibility and testing depth that smaller regional producers cannot easily replicate at comparable consistency. This refining advantage compounds over time as accumulated laboratory-certification relationships become increasingly difficult for newer entrants to match quickly across major nutraceutical accounts.
FF SKAGEN A/S

Risk: Narrower feedstock scale reach

FF Skagen's much narrower refining-focused feedstock footprint limits its commercial volume relative to Austevoll's established integrated fishing-to-refining capacity, a scale breadth difference that could slow broader commodity-segment penetration relative to more widely scaled competitors like Austevoll across the coming several years as demand keeps expanding steadily.
AUSTEVOLL SEAFOOD ASA

Moat: Integrated fishing-to-refining scale

Austevoll Seafood's dedicated vertical integration from harvesting through refining gives it cost efficiency and supply-security advantages among buyers seeking documented feedstock traceability that refining-only competitors without comparable upstream depth cannot easily replicate at comparable consistency. This integration advantage becomes especially valuable during periods of feedstock supply volatility affecting less diversified competitors more severely across the industry.
AUSTEVOLL SEAFOOD ASA

Risk: Reduction-fishery supply exposure

Austevoll's much heavier reliance on reduction-fishery-dependent feedstock exposes it more directly to ocean-condition catch restriction risk than nimbler refining-focused competitors built specifically around diversified sourcing, a growing customer segment increasingly prioritizing supply-chain reliability over established integrated-scale brand recognition. Diversified competitors are using this exposure gap to actively court its largest accounts.

Players Tracked

Prominent Players

FF Skagen A/S
Austevoll Seafood ASA
TASA (Tecnológica de Alimentos S.A.)
Omega Protein Corporation
Cermaq Group AS

Other Key Players

Copeinca ASA
Pesquera Diamante S.A.
Pesquera Hayduk S.A.
Oceana Group Limited
Ridley Corporation Limited
Pacific Andes International Holdings Limited
China Fishery Group Limited
Nissui Corporation
Maruha Nichiro Corporation
TripleNine Group
Scanbio Marine Group AS
Bioceval GmbH & Co. KG
Hofseth BioCare ASA
Nutrimar S.A.
CFG Investment S.A.C.

Recent Developments

MAY 2025

FF Skagen Launches Next-Generation Potency Certification Program

FF Skagen launched a new laboratory-verified potency certification program in May 2025, extending its Danish refining infrastructure into a documented purity-verification system designed for formulators seeking certified EPA and DHA concentration data without the disclosure complexity older supply arrangements carried. Early feedback reportedly cited improved buyer confidence.
Signal: Signals established refining majors now treat purity certification as central to defending category leadership against emerging challengers.
NOVEMBER 2024

Austevoll Seafood Expands Vietnamese Distribution Partnership

Austevoll Seafood expanded its distribution partnership across Vietnam in November 2024, a commercial distribution investment rather than an acquisition, formalizing its ability to serve the country's rapidly growing shrimp aquaculture sector at more competitive regional pricing. The expansion reportedly followed sustained regional demand growth from aquafeed formulators.
Signal: Indicates refining-focused producers are formalizing Asian distribution to defend regional market share more aggressively against domestic incumbents.
FEBRUARY 2025

TASA Launches Formulator Technical Support Partnership Program

TASA launched a new formulator technical support and grade-specification partnership program in February 2025, targeting nutraceutical buyers seeking trust-driven inclusion-rate guidance previously accessible mainly through smaller regional producers lacking comparable technical scale. The launch reportedly targets formulators previously underserved by generic marine-oil claims, offering documented technical support instead.
Signal: Shows major Peruvian producers are moving into mainstream trust-driven nutraceutical segments once dominated by established category leaders.

Reduction-Fishery Feedstock Anchors Refining Cost

Wild-catch reduction-fishery feedstock, primarily herring, mackerel, and anchoveta, represents roughly fifty-eight percent of cost of goods sold for a typical fishmeal and fish oil producer, sourced primarily from Norway, Peru, and Chile. Refined and pharma-grade formulations carry a meaningfully higher processing cost share given their reliance on additional testing and certification infrastructure across producing regions.
Global reduction-fishery catch volumes fluctuated meaningfully through 2021 and 2022 as ocean temperature anomalies disrupted Peruvian and North Atlantic populations, a volatility event documented in company annual filings and FAO fisheries market reporting, before stabilizing through 2023 and 2024 as ocean conditions normalized across most major producing regions. That volatility accelerated producer interest in sourcing diversification and refining capacity investment significantly across the industry. Several producers cited the episode directly when explaining subsequent sourcing-diversification investment.

Larger producers with diversified sourcing and integrated refining capacity absorbed the 2021 and 2022 catch volatility without major pricing increases, protecting nutraceutical customer relationships during the disruption, while smaller regional producers reliant on a single reduction fishery more often passed costs through immediately, risking the price-sensitive portion of their customer base at exactly the moment refined-format demand was accelerating fastest across several tracked regions and channels worldwide.
fishmeal-and-fish-oil-market-cost-volatility-analysis-1790398373230

Diversifying Sourcing Across Species and Geographies

Producers are diversifying sourcing across multiple fish species and producing regions, reducing dependence on any single reduction fishery or geography and giving procurement teams meaningfully more negotiating position during periods of catch volatility across the broader marine commodity sector that historically pressured smaller regional producers hardest during weak fishing seasons. This flexibility proved valuable during recent catch disruptions.

Building Integrated Refining and Processing Capacity

Building integrated, in-house refining and concentration capacity reduces dependence on external toll-processing arrangements entirely, giving producers meaningfully more control over cost, quality, and delivery timing than smaller competitors relying entirely on external refining arrangements typically achieve, especially during periods of broader feedstock disruption. Producers with this capacity weathered the 2021 and 2022 disruption meaningfully better than toll-dependent competitors.

Formalizing Long-Term Supply and Trade Agreements

Formalizing multi-year supply and trade agreements with key nutraceutical and aquafeed partners ahead of rising demand reduces exposure to the catch volatility that periodically affects this ocean-dependent input market with limited alternative sourcing infrastructure, a meaningful advantage as refined-format adoption continues scaling globally. These agreements give buyers more predictable planning horizons. These agreements give buyers more predictable planning horizons.

Portfolio Architecture for Margin Defence

The category organizes into three commercial tiers. A volume and commodity-adjacent tier competes on price using standard fishmeal and crude oil for commodity aquafeed inclusion, a premium and certified tier commands a real price premium tied to refined concentrate and specialty blends with dedicated technical support, and a smaller sustainability and next-generation tier built around nutraceutical and pharma-grade oil commands the strongest per-unit margin despite representing the smallest current volume base across the category overall today.
Refining capacity investment is concentrating premium tier growth among producers with established testing and quality-control infrastructure, while the volume tier remains genuinely competitive between global majors and regional producers fighting for the same price-sensitive smaller-importer segment across most producing countries. Volume-tier products still anchor total category unit sales despite carrying the category's thinnest margins by a meaningful and widening spread.

High-value margin pools concentrate in the sustainability and next-generation tier, where pharma-grade oil supports the strongest pricing power available today across the category, and in formulator-advised channels where producers can command premium pricing without facing the same cost sensitivity present across smaller-producer distribution segments. Producers able to defend both tiers simultaneously hold the strongest long-term competitive position worldwide today.

Volume / Commodity-Adjacent Tier

Standard fishmeal and crude oil competing primarily on price for commodity aquafeed inclusion, distributed broadly to commercial import channels worldwide with minimal certification documentation attached to the product. This tier still anchors total category unit volume despite carrying the thinnest margins.
Gross Margin: 14-20%

Premium / Certified Tier

Refined omega-3 concentrate and specialty blends carrying formal technical support and documented quality certification, merchandised at a meaningful price premium over crude oil. This tier is growing steadily among formulators seeking documented sourcing diversity.
Gross Margin: 24-32%

Sustainability / Regulatory / Next-Generation Tier

Nutraceutical and pharma-grade oil aimed at the most engaged, highest-spending commercial formulators, commanding the category's strongest per-unit margin despite still-limited volume relative to standard grades currently. Demand here is expanding fastest as more formulators prioritize verified purity compliance.
Gross Margin: 36-44%
fishmeal-and-fish-oil-market-portfolio-architecture-1790398373537

High-value Sub-segments and Strategic Watch-out

Nutraceutical and Pharma-Grade Fish Oil

This high-value, high-growth tier is expanding fastest as differentiated purity documentation reaches mainstream commercial credibility, making it the clearest near-term margin opportunity worldwide today. Early movers are securing certification capacity before entry compresses margins, since producers still lack meaningful pharma-grade capacity relative to fast-rising demand.
Gross Margin: 34-42%

Refined Concentrate Format Segment

High-value and steadily growing, refined omega-3 concentrate commands meaningful pricing power tied to genuine potency positioning and purity claims, though volume remains constrained relative to crude oil by continued refining infrastructure still scaling steadily. This segment benefits as premium supplement and aquafeed demand expands. Investment here continues accelerating steadily.
Gross Margin: 24-32%

Standard Crude Format

The volume core of the category, standard fishmeal and crude oil anchor total unit sales across commercial and export channels and remains the format most importers encounter first, even as refined formats capture growing category revenue share. This core segment stays largest by volume for years to come.
Gross Margin: 14-20%

Regional Producer Segment

The strategic watch-out segment, regional producers are narrowing the price gap with global majors fastest at the category's least differentiated price point, and their continued expansion could compress branded pricing power meaningfully absent further refining differentiation investment nationwide. This bears close monitoring across coming years ahead.
Gross Margin: 12-18%

From Bulk Commodity to Certified Concentrate

Fishmeal and fish oil demand behaves more like an annuity relationship once a formulator establishes a qualified supplier and grade specification, since repeat purchase frequency among converted buyers runs meaningfully higher than for occasional spot-market purchasers, giving producers a more predictable revenue base than the category's still-uneven refined-format penetration might otherwise suggest across mature and emerging markets tracked worldwide.
Adoption depth varies meaningfully by end-use vertical: large commercial aquafeed formulators show the deepest technical and grade-specification integration and highest repeat purchase rates given their systematic approach to long-term supply-contract protocols, nutraceutical and pharmaceutical formulators adopt more cautiously through phased trial programs before committing to an ongoing certified-format routine, and livestock feed manufacturers represent a distinct segment tied specifically to cost-driven bulk purchasing rather than premium positioning alone.

Younger formulation specialists entering the industry through purity-influenced procurement culture show meaningfully more comfort specifying certified concentrate than an older generation of buyers who relied primarily on conventional crude oil trading practices passed down across their own procurement experience, a generational shift reshaping how producers position refined products across their broader commercial outreach programs today across most markets.
fishmeal-and-fish-oil-market-end-use-penetration-index-1790398373837

Where MMA Sees the Real Opportunity

These are among the four positions where our research anticipates prominent divergence between winners and laggards over the coming forecast period. Each is grounded in the demand model, the regulatory perimeter, and the announced capacity pipeline.
01 / PURITY CERTIFICATION PRIORITY

Build laboratory documentation before rivals do

Purity certification remains the clearest lever for capturing formulator trust, and producers investing in genuine testing infrastructure now will hold a durable credibility advantage as competitors relying on limited certification struggle to match demonstrated purity-verification economics. Certification infrastructure takes meaningful time to develop and confirm properly across different production batches and testing facilities. Producers that delay risk losing this fast-growing tier to faster-moving certification-focused competitors already active in the category before it fully matures into a defensible commercial standard, and momentum is already compounding across leading accounts.
02 / REFINING CAPACITY STRATEGY

Build concentration infrastructure before rivals do

Dedicated refining capacity investment remains the single biggest lever for capturing premium-grade demand, and producers investing in genuine refining infrastructure now will hold a durable credibility advantage as competitors relying on crude-only processing struggle to match validated concentration economics. Refining infrastructure takes meaningful time to build and validate properly across different feedstock species and processing facilities. Producers that delay risk losing this fast-growing segment to faster-moving refining-focused competitors already active worldwide, and momentum here is already compounding across most major global markets tracked closely today.
03 / FORMULATOR RELATIONSHIP STRATEGY

Build technical programs before rivals do

Dedicated formulator relationship programs remain the clearest lever for capturing trust-driven demand, and producers investing in genuine technical support infrastructure now will hold a durable credibility advantage as competitors relying on self-marketed claims struggle to match validated advisory economics. Relationship infrastructure takes meaningful time to build and validate properly across different formulator networks and regional markets. Producers that delay risk losing this defensible position to faster-moving relationship-focused competitors already active in the category today across most major consuming markets tracked closely.
04 / EMERGING-MARKET DISTRIBUTION STRATEGY

Partner with formulators before competitors do

Asian market distribution partnerships provide a structured channel to reach fast-growing sophistication-driven consuming markets that conventional bulk-commodity distribution cannot access cost-effectively, and producers formalizing these partnerships now will establish access before competitors fully consolidate that relationship themselves across fast-growing markets. This partnership approach requires genuine investment in local relationship and technical grade-specification support rather than treating Asian markets as an afterthought opportunity. Producers that wait risk losing this fast-growing distribution channel to faster-moving competitors already establishing early relationships there, with momentum already compounding across leading regional accounts.

Engagement Snapshot From the Field

A live engagement with an industry participant carrying material or product regulatory and market exposure ahead of a defining policy shift, showing how our research translates into a defensible multi-year portfolio strategy.
MARKET MINDS ADVISORY · CLIENT ENGAGEMENT SUMMARY
Fishmeal And Fish Oil Producer Strategic Portfolio Review and Transition Roadmap 2026·Investment Scenario on Fishmeal And Fish Oil Exposure Evaluation 2025-26
CLIENT PROFILE
The client is a mid-sized Norwegian fish oil refiner reporting annual revenue of approximately 84 million dollars (client-reported, unverified by MMA) evaluating whether transitioning a meaningful share of its output from crude oil to refined nutraceutical-grade concentrate would justify the associated capital investment given intensifying buyer purity requirements. The refiner approached MMA to benchmark realistic transition timelines and cost outcomes before committing to the investment.
STRATEGIC CHALLENGE
Leadership needed to determine which refining technology and certification partnership would deliver the best combination of buyer credibility, purity verification, and cost given the refiner's existing feedstock relationships and appetite for capital investment. The refiner's leadership team also weighed timing risk carefully, since delaying the transition further risked losing preferred-supplier status with its primary nutraceutical buyer.
MMA APPROACH
MMA combined primary survey data with refiner and formulator interviews to benchmark realistic transition timelines and cost outcomes, modeled refining technology options across three commercial scenarios, and produced a phased grade-transition sequence tailored to the refiner's existing feedstock relationships and available budget. The engagement also included direct laboratory-testing review to validate certification body claims before finalizing recommendations.
KEY FINDINGS
  1. Refined nutraceutical-grade shipments achieved meaningfully higher buyer retention rates than continued crude oil trading across every tested formulator relationship. Results exceeded initial refiner projections meaningfully across the engagement.
  2. Certification documentation timelines exceeded refiner projections for the most complex multi-batch potency verification during peak processing seasons. Additional laboratory audit cycles were required before full transition.
  3. Simpler single-batch certification protocols achieved meaningfully faster validation timelines, making phased rollout essential to full transition success overall. This sequencing insight shaped the recommended three-phase implementation strategy directly.
  4. Bulk certification procurement across multiple production batches secured meaningfully better testing pricing than pursuing certification individually would have achieved. This pricing advantage strengthened the case for the formal certification partnership.
CLIENT PROFILE
The client is a mid-sized Norwegian fish oil refiner reporting annual revenue of approximately 84 million dollars (client-reported, unverified by MMA) evaluating whether transitioning a meaningful share of its output from crude oil to refined nutraceutical-grade concentrate would justify the associated capital investment given intensifying buyer purity requirements. The refiner approached MMA to benchmark realistic transition timelines and cost outcomes before committing to the investment.
STRATEGIC CHALLENGE
Leadership needed to determine which refining technology and certification partnership would deliver the best combination of buyer credibility, purity verification, and cost given the refiner's existing feedstock relationships and appetite for capital investment. The refiner's leadership team also weighed timing risk carefully, since delaying the transition further risked losing preferred-supplier status with its primary nutraceutical buyer.
MMA APPROACH
MMA combined primary survey data with refiner and formulator interviews to benchmark realistic transition timelines and cost outcomes, modeled refining technology options across three commercial scenarios, and produced a phased grade-transition sequence tailored to the refiner's existing feedstock relationships and available budget. The engagement also included direct laboratory-testing review to validate certification body claims before finalizing recommendations.
KEY FINDINGS
  1. Refined nutraceutical-grade shipments achieved meaningfully higher buyer retention rates than continued crude oil trading across every tested formulator relationship. Results exceeded initial refiner projections meaningfully across the engagement.
  2. Certification documentation timelines exceeded refiner projections for the most complex multi-batch potency verification during peak processing seasons. Additional laboratory audit cycles were required before full transition.
  3. Simpler single-batch certification protocols achieved meaningfully faster validation timelines, making phased rollout essential to full transition success overall. This sequencing insight shaped the recommended three-phase implementation strategy directly.
  4. Bulk certification procurement across multiple production batches secured meaningfully better testing pricing than pursuing certification individually would have achieved. This pricing advantage strengthened the case for the formal certification partnership.
RECOMMENDED STRATEGY
Phase 1: Phase 1 (Months 1 to 5): Launch pilot certification on the simplest single-batch production run to validate documentation assumptions and buyer readiness fully. Phase 2: Phase 2 (Months 6 to 13): Expand certification across remaining production batches with certification-body-supported audits and dedicated documentation support in place. Phase 3: Phase 3 (Months 14 to 18): Formalize long-term certified supply contracts based on full certification performance data collected throughout the engagement.
OUTCOME
Within four quarters of phased certification, the refiner reportedly achieved meaningfully higher buyer retention while maintaining comparable processing costs (client-reported, unverified by MMA), supporting a decision to formalize a long-term certified supply contract ahead of the original twenty-four-month timeline MMA had modeled for the full engagement.

Frequently Asked Questions

Foundational context covering the market sizes, CAGR, scope, country, region and competition that inform every finding below. This section is provided to cover basics and most often pre-purchase conversations, answered from the MMA Primary Research Dataset.

What is the current size of the Fishmeal And Fish Oil Market?

The global fishmeal and fish oil market reached approximately 12.5 billion dollars in 2025, driven primarily by aquaculture expansion and rising human omega-3 nutraceutical demand across major consuming regions.

How large will the Fishmeal And Fish Oil Market be by 2036?

MMA projects the market will reach roughly 19.86 billion dollars by 2036, supported by continued refined-concentrate adoption and expanding global aquaculture and nutraceutical demand. Norway's refining leadership should keep reinforcing that trajectory.

What is the CAGR for the Fishmeal And Fish Oil Market 2026 to 2036?

The market is projected to grow at a 4.3 percent compound annual rate between 2026 and 2036. This reflects the category's shift from crude commodity oil toward refined nutraceutical-grade concentrate sourcing.

Which segment is growing fastest?

Nutraceutical and pharma-grade fish oil is growing fastest, at roughly a 7.1 percent CAGR. This tier now delivers genuinely compelling purity documentation that formulators increasingly require.

Who are the major companies in the Fishmeal And Fish Oil Market?

FF Skagen, Austevoll Seafood, TASA, Omega Protein, and Cermaq Group lead the branded segment, though niche regional producers keep overall concentration comparatively low across the industry today.

Which country is growing fastest?

Norway is the fastest-growing country market, driven by rapid refining capacity investment and rising nutraceutical export demand. Vietnam shows a similarly strong adoption trajectory as commercial aquaculture expands.

Report Segmentation Architecture

The full report scope spans multiple orthogonal segmentation dimensions, with cross-tabulated demand data provided for each dimension pair. Coverage extends further to regional breakdowns, trend trajectories, and the competitive detail needed to support segment-level decision-making.

By Product Tier

  • Standard Fishmeal
  • Prime and Specialty Fishmeal
  • Crude Fish Oil
  • Refined Omega-3 Concentrate Fish Oil
  • Aquafeed-Grade Blends
  • Nutraceutical and Pharma-Grade Fish Oil

By End-Use Application

  • Aquafeed
  • Livestock and Swine Feed
  • Human Nutraceutical Supplements
  • Pharmaceutical Formulation

By Commercial Dimension

  • Export Commodity Trading Channel
  • Direct Long-Term Supply Contract Channel
  • Specialty Nutraceutical Distribution Channel
  • Toll-Refining Partnership Channel

By Region

  • North America
  • Western Europe
  • East Asia
  • South Asia and Pacific
  • Latin America
  • Middle East and Africa
  • Eastern Europe

Scope, Methodology, and Coverage

Every figure in this report is reproducible from documented input assumptions. The scope below maps the historical period, the forecast horizon, the segmentation dimensions, and the countries covered, alongside the underlying primary and qualitative methodology.
Historical Period
2020 to 2025
Forecast Period
2026 to 2036
Base Year
2025 (USD billions; MMA Primary Research Dataset, September 2026)
Market Definition
The fishmeal and fish oil market covers standard fishmeal, prime and specialty fishmeal, crude fish oil, refined omega-3 concentrate fish oil, aquafeed-grade blends, and nutraceutical and pharma-grade fish oil produced from wild-catch reduction fisheries and processing byproduct streams. It excludes plant-based omega-3 alternatives and algae-derived oil, and covers both the aquafeed and livestock feed application base and the human nutraceutical and pharmaceutical application base within a single combined co-product market.
Quantitative Units
USD billions (current prices); metric tons where disclosed
Segmentation Dimensions
By Product Tier; By End-Use Application; By Commercial Dimension; By Region
Regions Covered
North America, Western Europe, East Asia, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe
Countries Covered
USA, Canada, Norway, Denmark, Netherlands, UK, China, Japan, South Korea, Vietnam, Thailand, Australia, New Zealand, Peru, Chile, Brazil, South Africa, Gulf States, Poland, Russia
Key Companies Profiled
FF Skagen A/S, Austevoll Seafood ASA, TASA (Tecnológica de Alimentos S.A.), Omega Protein Corporation, Cermaq Group AS, Copeinca ASA, Pesquera Diamante S.A., Pesquera Hayduk S.A., Oceana Group Limited, Ridley Corporation Limited, Pacific Andes International Holdings Limited, China Fishery Group Limited, Nissui Corporation, Maruha Nichiro Corporation, TripleNine Group, Scanbio Marine Group AS, Bioceval GmbH & Co. KG, Hofseth BioCare ASA, Nutrimar S.A., CFG Investment S.A.C.
Quantitative Methodology
Primary survey, n=3,800 respondents, Q4 2025, six countries; demand-side model with trade association cross-validation
Qualitative Methodology
47 expert interviews, Q4 2025; applied to validate demand model assumptions, identify emerging dynamics, and assess competitive positioning
Report Format
PDF and XLSX data workbook (Word format preview document)
Publisher
Market Minds Advisory
Report Code
MMA-2026-AGR-172
Published
September 2026
Contact
sales@marketmindsadvisory.com | www.marketmindsadvisory.com

Purchase the full Fishmeal And Fish Oil Market Report (2026 to 2036).

The full report delivers a complete quantitative and qualitative assessment of the global fishmeal and fish oil market, including ten-year forecasts by product tier, region, and end-use application through 2036, with dedicated coverage distinguishing aquafeed commodity demand from nutraceutical premium demand. It profiles twenty companies with detailed moat and risk analysis for the two category leaders. The report includes primary survey data from 3,800 respondents across six countries and 47 expert interviews conducted in Q4 2025. Buyers also receive raw material cost modeling and revenue lever analysis alongside segmentation data and regional demand architecture.
Ten-year market forecasts by product tier and region
Competitive profiles of twenty global and specialty companies
Primary survey data from 3,800 respondents across six countries
Raw material cost modeling and mitigation strategy analysis
Revenue lever analysis across four commercial growth strategies
Regional demand architecture covering all seven global regions

Built For The People Who Decide

From boardroom strategy to bench-side execution, this report is read cover-to-cover by leaders shaping the next decade of their industry, turning demand scenarios, market dynamics and valuation benchmarks into decisions.
CXOs/ Presidents/ VPs/ Managers
M&A and Corporate Development
Strategy Teams and R&D Heads
Procurement and Product Directors
Regulatory and Compliance Leaders
Investor Relations and Equity Analysts